The history of the hepatitis B vaccine has been marked by controversies, from the ‘Australia antigen’ to the ‘Pediatric ...

Please provide your email address to receive an email when new articles are posted on . Global HBV incidence and mortality rates dropped from 1990 to 2021 among individuals aged 15 to 49 years.

Chronic hepatitis B (CHB) poses a major global health burden, with China particularly affected. Effective antiviral therapy ...

Switching to long-acting CAB/RPV was not linked to HBV reactivation or incident infection and may be a safe therapeutic option for most patients with HIV.

Please provide your email address to receive an email when new articles are posted on . The hepatitis B vaccine is safe and effective for preventing HBV infection in newborns. Universal HBV ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

The Centers for Disease Control and Prevention's (CDC’s) newly reworked Advisory Committee on Immunization Practices (ACIP) met Thursday to finally offer its recommendations for a universal hepatitis ...

Schematic representation of histone-modifying factor recruitment on cccDNA minichromosomes in relation to viral protein HBx. In the presence of HBx, histone-modifying factors such as p300/CBP, Set1A, ...

Person-to-person transmissions of hepatitis A have occurred across the United States and many are affecting gay and bisexual men. Hepatitis A outbreaks among MSM have been reported frequently despite ...

The International Agency for Research on Cancer (IARC) of the World Health Organization has classified hepatitis D virus (HDV) as carcinogenic, citing sufficient evidence and placing it alongside ...